CTLA4 and myeloid sarcoma: Inhibition of these co-stimulatory molecules using CTLA-4-Fc in experimental autoimmune encephalomyelitis, an animal model of MS, has been effective in decreasing inflammation and demyelination [43], but there are few reports on NMOSD.